Tahithromos’s PennyMac Mortgage Investment PMT Stock Holding History

Tahithromos’s Portfolio PMT Stock Details PMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-57,518	Closed	-$1.05M	–	19
2017 Q2	$1.05M	Sell	57,518 -344	-0.6%	-$6.12K	1.12%	13
2017 Q1	$1.03M	Buy	57,862 +29,352	+103%	+$497K	1.29%	15
2016 Q4	$467K	Buy	+28,510	New	+$451K	0.56%	20

Other funds holding PMT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GXMC

Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Tahithromos's PMT Position: Q3 2017 in Review

Tahithromos sold out of PennyMac Mortgage Investment (PMT) in Q3 2017, closing a stake of 57,518 shares — an estimated $1.05M sold.

Tahithromos first reported a position in PMT in Q4 2016 and held it in 3 quarters. The position peaked at $1.05M in Q2 2017. 154 funds tracked by Wall St. Rank hold PMT as of Q3 2017.

Tahithromos reported no remaining PennyMac Mortgage Investment position as of Q3 2017 after selling out during the quarter.
Tahithromos sold 57,518 PennyMac Mortgage Investment shares in Q3 2017, an estimated $1.05M.
Tahithromos first reported a position in PennyMac Mortgage Investment in Q4 2016 and held it in 3 quarters.
Tahithromos's PennyMac Mortgage Investment position peaked at $1.05M in Q2 2017.
154 funds tracked by Wall St. Rank held PennyMac Mortgage Investment as of Q3 2017.

Based on Tahithromos's 13F filing for Q3 2017, filed 9 Nov 2017.